Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $5.30 per share, beating the Zacks Consensus Estimate of$ 4.68 per share. This compares to earnings of $4.51 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 13.25%. A quarter ago, it was expected that this drugmaker would post earnings of$ 4.14 per share when it actually produced earnings of $2.68, delivering a surprise of -35.27%. Over the last four quarters, th ...